Upashita IV injection for dialysis 200μg syringe, manufactured by Sanwa Chemical Research Institute, contains Upacicalcet sodium hydrate. This calcimimetic agent increases the sensitivity of calcium-sensing receptors on parathyroid glands to help manage secondary hyperparathyroidism in patients undergoing hemodialysis. It is provided as a 200μg/1mL/1 tube injectable drug (YJ code: 3999460G5027).
Upashita IV injection for dialysis 200μg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →